Medable
The mental health company will use Curebase's decentralized clinical trial platform to study its treatment program's efficacy.
The partnership will allow Withings' connected scales, blood pressure monitors and sleep-tracking mats to integrate with Medable's trial platform.
The new partnership is focused on expanding access to clinical trials for patients from diverse backgrounds.
The new acquisition will further Medable's European expansion efforts.
This new funding round brings the company's total raise to $521 million.
Also: bink health names Elizabeth Mora and Naomi Kelman to its board of directors, and Mandana Varahrami will join CipherHealth.
Also: Fern Health gets a new CEO, SonderMind grows executive leadership team by two and Twentyeight Health names new hires.
The company's drug development CRO, Covance, will integrate Medable's software to expand its decentralized trial capabilities.
This new investment brings the company's total funding to $45 million.
San Francisco-based accelerator Launchpad Digital Health funded its first five companies this week.